Balaji Laxmanan

Balaji Laxmanan, MD, DAABIP is a Senior Director of Clinical Development at Johnson & Johnson, focusing on the Lung Cancer Initiative. With a background in interventional pulmonology and critical care, Balaji has experience as an attending physician and has completed fellowships in interventional pulmonary and pulmonary/critical care medicine. Prior to their current role, Balaji worked as an interventional pulmonologist at Confluence Health. Balaji holds an MD from the University of Michigan Medical School and a BS in Molecular Biology and Economics.